Intel Could Reprice Altera, and AMD Is the Rival Watching Closest

Intel may be about to get a new price tag on one of its most closely watched side projects. Market attention is turning to a possible fresh valuation of Altera, the programmable chip business Intel has been loosening its grip on, and analysts say the competitor to watch is AMD.

Altera makes field-programmable gate arrays, or FPGAs, chips that customers can reconfigure after manufacture. They are used in networking gear, industrial systems, defense electronics and data centers. Intel bought the company in 2015 and, in 2025, sold a majority stake to private equity firm Silver Lake at a valuation of roughly $8.75 billion, keeping a minority interest for itself.

That minority stake is why a new valuation matters. If Altera is priced meaningfully above the 2025 deal level, whether through a funding round, a stake sale or a public listing, the value of what Intel still holds rises with it. That would give Intel a cleaner, market-tested figure to point to at a time when it is working to shore up its balance sheet and sharpen its focus on core chip design and manufacturing.

AMD is the natural yardstick. It bought Xilinx, the other big name in FPGAs, in a deal valued at around $49 billion that closed in 2022. Xilinx now sits inside AMD's embedded segment, so any new Altera price will invite direct comparisons. A higher figure would suggest the market still values programmable silicon, including its growing role in edge computing and AI inference. A lower one would raise questions about how much AMD paid for its own FPGA franchise and how fast that business can grow.

The competitive picture matters as much as the accounting. Altera is operating more independently, with its own management and strategy, and it is trying to win back share from Xilinx in a market where the two have long dominated. Fresh outside capital or a public listing could give it more room to invest in new products and chase customers that previously defaulted to AMD.

For investors, the takeaways are fairly simple. Intel could see a mark-to-market boost on its retained stake, though the size is unclear and depends on how any deal is structured. AMD is unlikely to be hurt directly in the near term, but it will be measured against whatever number emerges. Details on timing and pricing have not been confirmed, so the story is one to track rather than trade on today.